AND CONTROL |
COLLOQUIUM |
|
Dr. Yakar is a Staff Scientist in the Diabetes Branch of the National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, in Bethesda, Maryland. |
To learn if circulating (serum) IGF-1 can serve as a cancer risk marker |
Researchers and clinicians actively involved in topics that relate to cancer prevention and control |
Wednesday, November 17,
2004, 11:00 am |
Office of Preventive
Oncology |
If you are a person with a disability and require any assistive device, services or other reasonable accommodations to participate in this activity, please contact the Office of Preventive Oncology at 301-496-8640 at least one week in advance of the lecture date to discuss your accommodations needs.
Home Page |
Home Page |
Home Page |
Home Page |